Clincosm LogoSign in Get a demo

Message From Local Pharmacy Team

Sponsor
University of Pennsylvania (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05613764
Collaborator
(none)
520,000
Enrollment
1
Location
2
Arms
3.2
Anticipated Duration (Months)
163170.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination that comes from a patient's local pharmacy team and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination that come from a patient's local pharmacy team will produce more vaccinations than otherwise identical messages.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: COVID Booster text messages
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
520000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomly assigned to the different arms.Participants will be randomly assigned to the different arms.
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
As treated participants will receive text messages, there is no scope for blinding. Care providers will not be made aware of subjects' participation in the study, or assigned treatment arms. The study team will only receive data on subjects' assigned arms and outcomes at the end of the study.
Primary Purpose:
Health Services Research
Official Title:
Message From Local Pharmacy Team
Actual Study Start Date :
Nov 3, 2022
Actual Primary Completion Date :
Dec 8, 2022
Anticipated Study Completion Date :
Feb 8, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control condition with "waiting for you" message

This control condition will use the text message that the investigators found to be the best performing in their last mega-study of vaccine text messages to recommend a COVID vaccination.

Behavioral: COVID Booster text messages
Participants will receive text messages per descriptions listed in the arms
Experimental: Message from local pharmacy team

This condition will use a text message from the participant's local pharmacist recommending a COVID vaccination.

Behavioral: COVID Booster text messages
Participants will receive text messages per descriptions listed in the arms

Outcome Measures

Primary Outcome Measures

  1. Patient uptake of COVID bivalent booster [During the 30 days after receiving the SMS/MMS intervention]

    Whether patients receive a bivalent COVID booster at the pharmacy in question

Secondary Outcome Measures

  1. Patient uptake of COVID bivalent booster [60 days after receiving the SMS/MMS intervention]

    Whether patients receive a bivalent COVID booster at the pharmacy in question

  2. Patient uptake of COVID bivalent booster [90 days after receiving the SMS/MMS intervention]

    Whether patients receive a bivalent COVID booster at the pharmacy in question

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Exclusion Criteria:

  1. The patient unsubscribed from texts before the send date and time of the patient's SMS/MMS message

  2. The patient received a bivalent COVID booster before the send date and time of the patient's SMS/MMS message.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT05613764
Other Study ID Numbers:
  • 851911-Trial D
First Posted:
Nov 14, 2022
Last Update Posted:
Jan 5, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Pennsylvania
COVID-19
behavioral science interventions
vaccination promotion
Additional relevant MeSH terms:
COVID-19

Study Results

No Results Posted as of Jan 5, 2023